INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC
NEW YORK, Nov. 3, 2024 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of BM Technologies, Inc. – BMTX
NEW YORK, Nov. 3, 2024 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – AVTE
NEW YORK, Nov. 3, 2024 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Altair Engineering Inc. – ALTR
NEW YORK, Nov. 3, 2024 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Profire Energy, Inc. – PFIE
NEW YORK, Nov. 3, 2024 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State
New SELECT trial analysis with semaglutide 2.4 mg showed a significant reduction in hospital admissions in adults with known heart disease and obesity or overweight
Results from Novo Nordisk, presented at ObesityWeek®, showed treatment with semaglutide injection 2.4 mg resulted in significant reductions in hospital admissions as well as overall time spent in the hospital1 Cardiovascular disease represents the leading cause of death globally,2 and adults with o
ARRAY Innovation Celebrates Landmark Success at Gateway Gulf with Three Major Partnership Deals
MANAMA, Bahrain, Nov. 3, 2024 /PRNewswire/ — ARRAY Innovation, the Bahrain-based leader in AI, enterprise software, and cloud solutions, proudly celebrated a milestone at Gateway Gulf 2024. During the event, organized by the Bahrain Economic Development Board (EDB) in the Kingdom of Bahrain, A
Outstanding Achievement in Writing Recognized: Professor of Law and Dean Emeritus of Ave Maria School of Law, Eugene Milhizer Named a Gold Medal Winner in Royal Palm Literary Awards 2024
NAPLES, Fla., Nov. 3, 2024 /PRNewswire/ — The Florida literary world is abuzz with excitement as Professor Milhizer, a talented and accomplished writer, was announced as a winner in the esteemed Royal Palm Literary Awards (RPLA). Hosted annually by the Florida Writers Association (FWA), RPLA
DAZN AND QUEENSBERRY PROMOTIONS ANNOUNCE HISTORIC GLOBAL MEDIA RIGHTS DEAL
From 1 April 2025, DAZN will be the exclusive global broadcast partner of Queensberry Promotions, bringing its elite boxing events to fans worldwide for the first time. DAZN to unify premium boxing content on a single platform with Queensberry joining Matchroom, Golden Boy Promotions, Misfits and
Media advisory – Government of Canada to announce proposed approach to tackle greenhouse gas pollution and drive innovation in the oil and gas sector
OTTAWA, ON, Nov. 3, 2024 /CNW/ – Media representatives are advised that the Honourable Steven Guilbeault, Minister of Environment and Climate Change, and the Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, joined by colleagues, will announce the Government of Canada&#
